BuyMeWhiskeyStock analysisAnswersSBRA news
Home › Stock analysis › SBRA

Sabra Health Care REIT (SBRA) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET

Updated Oct 15, 2026, 4:00 PM ET

What changed since yesterday

SBRA rises 0.6% to $19.29. Closed at $19.29, +0.63% vs the prior close of $19.17. Day range $19.26–$19.67, opened at $19.61.

Last close$19.29+0.63%
Day range19.26–19.67
Open19.61
Volume2.19M
52-week range17.17–22.77
Avg volume (20d)2.57M

SBRA daily analysis — what happened

A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.

Oct 15, 2026 — SBRA rises 0.6% to $19.29
Oct 14, 2026 — SBRA dips 0.7% to $19.17
Oct 13, 2026 — SBRA rises 0.6% to $19.31, 4 up days in a row
Oct 12, 2026 — SBRA rises 1.3% to $19.20, 3 up days in a row
Oct 9, 2026 — SBRA rises 0.6% to $18.96
Oct 8, 2026 — SBRA rises 0.5% to $18.84
Oct 7, 2026 — SBRA dips 2.0% to $18.74, a 3-month low
Oct 6, 2026 — SBRA ends flat (+0.3%) to $19.12
Oct 5, 2026 — SBRA dips 0.5% to $19.07, a 3-month low, 6 down days in a row
Oct 2, 2026 — SBRA ends flat (-0.2%) to $19.16, a 3-month low, 5 down days in a row

SBRA latest news & SEC filings

Every SEC filing by or about SBRA in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.

Sep 9, 2026 · 4 — Insider trade report (Form 4)

Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings

Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.

Source: SEC EDGAR filing 0001184158-26-000016

Sep 8, 2026 · 144 — Notice of proposed sale (Form 144)

Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares

A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.

Source: SEC EDGAR filing 0001628280-26-060841

Sep 2, 2026 · 4 — Insider trade report (Form 4)

Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings

Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).

Source: SEC EDGAR filing 0002104848-26-000012

Sep 2, 2026 · 4 — Insider trade report (Form 4)

Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings

Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).

Source: SEC EDGAR filing 0001650988-26-000010

Sep 2, 2026 · 4 — Insider trade report (Form 4)

Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings

Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).

Source: SEC EDGAR filing 0001837209-26-000010

Sep 2, 2026 · 4 — Insider trade report (Form 4)

Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings

Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).

Source: SEC EDGAR filing 0001770419-26-000010

Aug 3, 2026 · 10-Q — Quarterly report (unaudited financial statements for the quarter)

Quarterly report (unaudited financial statements for the quarter)

Quarter ended Jun 30, 2026:

Source: SEC EDGAR filing 0001492298-26-000028

Aug 3, 2026 · 8-K — Current report

Current report — a filing companies must make within 4 business days of a major event

This is a results-day filing: the earnings press release is attached as an exhibit.

Source: SEC EDGAR filing 0001492298-26-000027

Jul 21, 2026 · 8-K — Current report

Current report — a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001492298-26-000023

Things to know before you trade SBRA

SBRA market data (last 20 sessions)

DateOpenHighLowCloseVolume
Oct 15, 202619.6119.6719.2619.292.19M
Oct 14, 202619.2319.3719.0919.172.21M
Oct 13, 202619.5319.5319.0819.312.71M
Oct 12, 202618.9319.2318.8619.202.01M
Oct 9, 202618.8719.0918.8618.961.39M
Oct 8, 202618.7719.0018.5818.841.99M
Oct 7, 202619.1619.2018.7318.742.22M
Oct 6, 202619.0519.1918.9019.122.82M
Oct 5, 202619.0319.3718.9919.073.71M
Oct 2, 202619.2719.4219.0119.163.06M
Oct 1, 202619.5819.6419.1519.203.21M
Sep 30, 202619.8619.9619.6919.722.50M
Sep 29, 202619.7719.9719.6319.782.28M
Sep 28, 202619.8519.9619.6919.821.86M
Sep 25, 202619.7519.8919.5919.852.30M
Sep 24, 202619.7720.0619.7419.772.14M
Sep 23, 202619.7819.9119.6619.693.03M
Sep 22, 202619.9519.9719.7619.812.25M
Sep 21, 202619.7820.0919.7119.872.01M
Sep 18, 202620.0720.1019.6919.745.47M

About Sabra Health Care REIT

Sabra Health Care REIT (SBRA) is listed on the Nasdaq and classified by the SEC under “Real Estate Investment Trusts”. Its business address is in TUSTIN, CA. State of incorporation: MD. Fiscal year ends December 31. SEC CIK 1492298.

SBRA board of directors & executives

From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).

Directors

NameRoleLatest filing
Craig A. BarbaroshDirectorSep 2, 2026
Catherine CusackDirectorSep 2, 2026
Michael J FosterDirectorSep 2, 2026
Lynne S KatzmannDirectorSep 2, 2026
Ann KonoDirectorSep 2, 2026
Richard K MatrosChair, CEO and PresidentSep 9, 2026
Jeffrey A. MalehornDirectorSep 2, 2026

Executive officers

NameTitleLatest filing
Michael Lourenco CostaExecutive VP, CFO & TreasurerSep 2, 2026
Jessica FloresExecutive VP & CAOSep 2, 2026
Richard K MatrosChair, CEO and PresidentSep 9, 2026
Talya Nevo-HacohenExecutive VP, CIO & TreasurerDec 2, 2025
Darrin SmithExecutive VP, CIO & SecretarySep 2, 2026

Recent insider buys & sales

DateInsiderTypeSharesPrice
Sep 8, 2026Richard K MatrosSale200,000$20.83
Mar 25, 2026Jessica FloresSale15,231$19.86

SBRA financials (annual, from XBRL filings)

Fiscal year endRevenueNet incomeDiluted EPSOperating cash flow
Dec 31, 2025$356.88M$155.61M0.64$348.61M
Dec 31, 2024$284.58M$126.71M0.54$310.54M
Dec 31, 2023$236.15M$13.76M0.06$300.57M
Dec 31, 2022$186.67M$-77.61M-0.34$315.73M
Dec 31, 2021$155.51M$-113.26M-0.52$356.39M

Latest balance sheet: total assets $5.51B, total liabilities $2.76B, cash $231.58M (as of Jun 30, 2026).

SBRA earnings / results-day log

DateFilingClose that day
Aug 3, 20268-K Item 2.02 (results)$20.61
Apr 29, 20268-K Item 2.02 (results)$20.35
Feb 12, 20268-K Item 2.02 (results)$20.25
Nov 5, 20258-K Item 2.02 (results)$18.20
Aug 4, 20258-K Item 2.02 (results)$18.41
May 5, 20258-K Item 2.02 (results)$17.28
Feb 19, 20258-K Item 2.02 (results)$16.55
Oct 31, 20248-K Item 2.02 (results)$19.40
Aug 7, 20248-K Item 2.02 (results)—
May 8, 20248-K Item 2.02 (results)—
Feb 27, 20248-K Item 2.02 (results)—
Nov 6, 20238-K Item 2.02 (results)—

Related stocks · Real Estate Investment Trusts

Welltower (WELL)Prologis (PLD)Equinix (EQIX)American Tower (AMT)Simon Property (SPG)Realty Income (O)Digital Realty (DLR)Ventas (VTR)Public Storage (PSA)Crown Castle (CCI)

Popular today

Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)

More on SBRA

Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.